Lundbeck, Sandoz end long-running Lexapro patent war

Intellectual Property 2025-02-27 11:06 pm By Christine Caulfield

Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.